Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5268102
Max Phase: Preclinical
Molecular Formula: C44H56Cl2N2O16
Molecular Weight: 939.84
Associated Items:
ID: ALA5268102
Max Phase: Preclinical
Molecular Formula: C44H56Cl2N2O16
Molecular Weight: 939.84
Associated Items:
Canonical SMILES: CO[C@@H]1[C@H](O[C@@H]2CO[C@@H](O[C@@H]3[C@@H](O)[C@H](O)CO[C@H]3N3C(=O)/C(=C(O)/C=C/C=C/C=C/C=C/C=C(Cl)/C=C/C=C/C=C/[C@@H]4O[C@H](C)C[C@@H]4Cl)C(=O)[C@@H]3CC(N)=O)[C@@H](O)[C@@H]2O)O[C@H](C)[C@H]1O
Standard InChI: InChI=1S/C44H56Cl2N2O16/c1-23-19-26(46)30(61-23)18-14-10-9-12-16-25(45)15-11-7-5-4-6-8-13-17-28(49)33-35(53)27(20-32(47)51)48(41(33)57)42-39(36(54)29(50)21-59-42)64-43-38(56)37(55)31(22-60-43)63-44-40(58-3)34(52)24(2)62-44/h4-18,23-24,26-27,29-31,34,36-40,42-44,49-50,52,54-56H,19-22H2,1-3H3,(H2,47,51)/b5-4+,8-6+,10-9+,11-7+,16-12+,17-13+,18-14+,25-15-,33-28-/t23-,24-,26+,27+,29-,30+,31-,34-,36+,37-,38+,39-,40+,42-,43+,44+/m1/s1
Standard InChI Key: HSOZLYVGPBGNQK-ZNNYHUTBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 939.84 | Molecular Weight (Monoisotopic): 938.3007 | AlogP: 1.30 | #Rotatable Bonds: 17 |
Polar Surface Area: 266.46 | Molecular Species: ACID | HBA: 16 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 5.07 | CX Basic pKa: | CX LogP: 1.16 | CX LogD: -1.15 |
Aromatic Rings: 0 | Heavy Atoms: 64 | QED Weighted: 0.04 | Np Likeness Score: 1.55 |
1. Govindarajan M.. (2018) Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics., 143 [PMID:29126728] [10.1016/j.ejmech.2017.10.015] |
Source(1):